Why This Diagnostics Stock Is a Buy

A sure sign of a wonderful stock is one that consistently beats analysts' forecasts. Well, Quest Diagnostics (NYSE: DGX) managed to exceed analysts' expectations in the third-quarter earnings report on Oct. 21 for the period ending Sep. 30. It marked the ninth quarter out of the past 10 that the company has topped earnings per share (EPS) predictions. 

Why do I believe Quest Diagnostics is a buy for dividend growth-oriented investors? Let's take a look at three reasons.

Image source: Getty Images.

Continue reading

Source Fool.com